Smyła-Gruca Wiktoria, Szczurek-Wasilewicz Wioletta, Skrzypek Michał, Karmański Andrzej, Romuk Ewa, Jurkiewicz Michał, Gąsior Mariusz, Szyguła-Jurkiewicz Bożena
Student's Scientific Society, 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
Silesian Center for Heart Diseases, 41-800 Zabrze, Poland.
Biomedicines. 2024 Mar 15;12(3):662. doi: 10.3390/biomedicines12030662.
The role of oxidative/antioxidative system imbalances in advanced heart failure (HF) has not been fully investigated. The aim of this study was to identify factors associated with one-year mortality in patients with advanced HF, with particular emphasis on oxidative/antioxidative balance parameters. We analyzed 85 heart transplant candidates who were hospitalized at our institution for right heart catheterization. Ten milliliters of coronary sinus blood was collected to measure oxidative/antioxidative markers. The median age was 58 (50-62) years, and 90.6% of them were male. The one-year mortality rate was 40%. Multivariable logistic regression analysis revealed that ceruloplasmin (OR = 1.342 [1.019-1.770], = 0.0363; per unit decrease), catalase (OR = 1.053 [1.014-1.093], = 0.0076; per unit decrease), and creatinine (OR = 1.071 [1.002-1.144], = 0.0422; per unit increase) were independently associated with one-year mortality. Ceruloplasmin, catalase, and creatinine had areas under the curve of 0.9296 [0.8738-0.9855], 0.9666 [0.9360-0.9971], and 0.7682 [0.6607-0.8756], respectively. Lower ceruloplasmin and catalase in the coronary sinus, as well as higher creatinine in peripheral blood, are independently associated with one-year mortality in patients with advanced HF. Catalase and ceruloplasmin have excellent prognostic power, and creatinine has acceptable prognostic power, allowing the distinction of one-year survivors from nonsurvivors.
氧化/抗氧化系统失衡在晚期心力衰竭(HF)中的作用尚未得到充分研究。本研究的目的是确定晚期HF患者一年死亡率的相关因素,特别强调氧化/抗氧化平衡参数。我们分析了85名在我院因右心导管插入术住院的心脏移植候选者。采集10毫升冠状窦血以测量氧化/抗氧化标志物。中位年龄为58(50 - 62)岁,其中90.6%为男性。一年死亡率为40%。多变量逻辑回归分析显示,铜蓝蛋白(OR = 1.342 [1.019 - 1.770],P = 0.0363;每单位降低)、过氧化氢酶(OR = 1.053 [1.014 - 1.093],P = 0.0076;每单位降低)和肌酐(OR = 1.071 [1.002 - 1.144],P = 0.0422;每单位升高)与一年死亡率独立相关。铜蓝蛋白、过氧化氢酶和肌酐的曲线下面积分别为0.9296 [0.8738 - 0.9855]、0.9666 [0.9360 - 0.9971]和0.7682 [0.6607 - 0.8756]。冠状窦中较低的铜蓝蛋白和过氧化氢酶,以及外周血中较高的肌酐,与晚期HF患者的一年死亡率独立相关。过氧化氢酶和铜蓝蛋白具有出色的预后预测能力,肌酐具有可接受的预后预测能力,能够区分一年存活者和非存活者。